S
Shahanavaj Khan
Researcher at King Saud University
Publications - 40
Citations - 864
Shahanavaj Khan is an academic researcher from King Saud University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 16, co-authored 33 publications receiving 605 citations. Previous affiliations of Shahanavaj Khan include Jamia Millia Islamia.
Papers
More filters
Journal ArticleDOI
FGFR a promising druggable target in cancer: Molecular biology and new drugs
Rut Porta,Roberto Borea,Andreia Coelho,Shahanavaj Khan,António Araújo,Pablo Reclusa,Tindara Franchina,Nele Van Der Steen,Peter van Dam,Jose Ferri,Rafael Sirera,Aung Naing,David S. Hong,Christian Rolfo +13 more
TL;DR: This review summarizes the current status of treatments targeting FGFR, focusing on the trials that are evaluating the FGFR profile as inclusion criteria: Multi-Target, Pan-FGFR Inhibitors and anti-FGF (Fibroblast Growth Factor)/FGFR Monoclonal Antibodies.
Journal ArticleDOI
Biology, Pathophysiological Role, and Clinical Implications of Exosomes: A Critical Appraisal
TL;DR: The antigen-presenting and immune-stimulatory properties of exosomes enable them to trigger anti-tumor responses, and exosome release from cancerous cells suggests they contribute to the recruitment and reconstitution of components of tumor microenvironments.
Journal ArticleDOI
Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design.
TL;DR: In vitro drug release data were fitted in different kinetic models and pattern of drug release followed Higuchi-matrix type, and factors A, B and C were found to give synergistic effect on R1, while factor A has a negative impact on R2 and R3.
Journal ArticleDOI
In vitro evaluation of anticancer and antibacterial activities of cobalt oxide nanoparticles
TL;DR: Co3O4-NPs showed promising anticancer activity against HT29 and SW620 cells with IC50 value of 2.26 and 394.5 μg/mL, respectively, however, no significant effect of Co3O5NPs was observed against bacterial strains.
Journal ArticleDOI
Evaluation of in vitro cytotoxicity, biocompatibility, and changes in the expression of apoptosis regulatory proteins induced by cerium oxide nanocrystals.
Shahanavaj Khan,Anees A. Ansari,Christian Rolfo,Andreia Coelho,Maha Abdulla,Khayal Al-Khayal,Rehan Ahmad +6 more
TL;DR: This study revealed anticancer effects of CeO2-NCs in HT29 and SW620 colorectal cancer cell lines with half-maximal inhibitory concentration values of 2.26 and 121.18 μg ml–1, respectively.